You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0434 Pharmacodynamic effects and safety of verinurad (RDEA3170) in combination with febuxostat versus febuxostat alone in adults with gout: a phase 2a, open-label study

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
THU0434 Pharmacodynamic effects and safety of verinurad (RDEA3170) in combination with febuxostat versus febuxostat alone in adults with gout: a phase 2a, open-label study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fleischmann R, Winkle P, Hall J, et al
THU0434 Pharmacodynamic effects and safety of verinurad (RDEA3170) in combination with febuxostat versus febuxostat alone in adults with gout: a phase 2a, open-label study
Annals of the Rheumatic Diseases 2017;76:371.